Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CLDN6 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CLDN6 expression	Testicular Cancer	CLDN6 expression	Testicular Cancer	TORL-1-23 Sensitive: C3 – Early Trials ASCO 2023 - 6 days (New C3) TORL-1-23 Sensitive : C3 ASCO 2023 - 6d	TORL-1-23 Sensitive: C3 – Early Trials ASCO 2023 - 6 days TORL-1-23 Sensitive : C3 ASCO 2023 - 6 days - (New C3)
CLDN6 expression	Ovarian Cancer	CLDN6 expression	Ovarian Cancer	TORL-1-23 Sensitive: C3 – Early Trials ASCO 2023 - 6 days (New C3) TORL-1-23 Sensitive : C3 ASCO 2023 - 6d	TORL-1-23 Sensitive: C3 – Early Trials ASCO 2023 - 6 days TORL-1-23 Sensitive : C3 ASCO 2023 - 6 days - (New C3)
CLDN6 expression	Non Small Cell Lung Cancer	CLDN6 expression	Non Small Cell Lung Cancer	AMG 794 Sensitive: C2 – Inclusion Criteria AMG 794 Sensitive : C2	AMG 794 Sensitive: C2 – Inclusion Criteria AMG 794 Sensitive : C2
CLDN6 expression	Ovarian Cancer	CLDN6 expression	Ovarian Cancer	AMG 794 Sensitive: C2 – Inclusion Criteria AMG 794 Sensitive : C2	AMG 794 Sensitive: C2 – Inclusion Criteria AMG 794 Sensitive : C2
CLDN6 expression	Solid Tumor	CLDN6 expression	Solid Tumor	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D
CLDN6 expression	Endometrial Cancer	CLDN6 expression	Endometrial Cancer	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D
CLDN6 expression	Ovarian Cancer	CLDN6 expression	Ovarian Cancer	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D	CTIM-76 Sensitive: D – Preclinical CTIM-76 Sensitive : D